Biodistribution in normal mice of an111in-labelled prostatic acid phosphatase-specific antibody and its F(ab?)2 fragments derivatized site-specifically or via bicyclic diethyl enetriaminepentaacetic acid anhydride
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 16 (8-10) , 621-626
- https://doi.org/10.1007/bf00998159
Abstract
In this study we examined optimization of derivatization of monoclonal antibodies and their fragments intended for use as radiopharmaceutical in radioimaging and/or radioimmunotherapy of prostatic cancer. Two different principles were used to conjugate diethylene triaminepentaacetic acid (DTPA) to a monoclonal antibody (Mab, subclass IgG1) raised against human prostatic acid phosphatase (PAP). In addition, the F(ab′)2 fragments of this Mab were also derivatized. We used the cyclic anhydride of DTPA (CA-DTPA) as a chelating agent for these two protein moieties. Furthermore, the Mab and the F(ab′)2 fragments were modified site-specifically by attaching linkers,N-(p-aminobenzyl)diethylenetriaminetetraacetic acid (p-NH2-Bz-DTTA) and 1(p-aminobenzyl)diethylenetriaminepentaacetic acid (p-NH2-Bz-DTPA), to the carbohydrate components of the parent molecules. In this study, biodistribution of the111In-labelled derivatives was investigated in normal mice. All the derivatives of IgG1 demonstrated a slower blood clearance than the corresponding derivatives of the F(ab′)2 fragments. This property was particularly pronounced in the site-specifically conjugated derivatives of IgG1. All the derivatives studied accumulated in the liver, kidney, and spleen. The CA-DTPA derivatives of F(ab′)2 fragments showed the highest kidney-to-blood ratios of radioactivity compared with the other compounds studied. The derivatives of IgG1 showed a higher percentage of the injected dose in liver and spleen tissues than the derivatives of the F(ab′)2 fragments. The F(ab′)2 fragments studied also gave rise to site-specific derivatives, which demonstrated that carbohydrates were also present in this part of the molecule. They behaved similarly to the CA-DTPA F(ab′)2 derivative in other respects, but the kidney accumulation was lower at 72 and 120 h. The F(ab′)2 fragments studied would be better suited for radioimaging than the derivatives of the IgG1 studied due to the rapid blood clearance of the F(ab′)2 derivatives. In contrast, the derivatives of IgG1, especially thep-NH2-Bz-DTPA conjugate, which showed the lowest kidney uptake, might be more suitable candidates for the development of therapeutic agents.Keywords
This publication has 22 references indexed in Scilit:
- Radiolabelling of monoclonal antibodies: Optimization of conjugation of DTPA to F(ab?) 2-fragments and a novel measurement of the degree of conjugation using Eu(III)-labellingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1989
- Purification of monoclonal antibodies raised against prostate-specific acid phosphatase for use in vivo in radioimaging of prostatic cancerJournal of Immunological Methods, 1989
- Preparation of F(ab′)2 fragments from monoclonal mouse IgG1 suitable for use in radioimagingJournal of Immunological Methods, 1988
- Labeling of the oligosaccharide moieties of immunoglobulinsJournal of Immunological Methods, 1987
- Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinomaThe Prostate, 1987
- Site-specifically modified 111In labelled antibodies give low liver backgrounds and improved radioimmunoscintigraphyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- Radiolabeling of monoclonal antibodiesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studiesInorganic Chemistry, 1986
- 90Y-labeled monoclonal antibodies for cancer therapyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody.European Journal of Nuclear Medicine and Molecular Imaging, 1985